Welcome!

News Feed Item

Philadelphia's First Ride to Conquer Cancer Launches To Raise Vital Funds For Penn Medicine's Abramson Cancer Center

Funds raised through 150 mile cycling event will support breakthrough research, education and patient care.

PHILADELPHIA, Jan. 28, 2014 /PRNewswire/ -- Philadelphia's first annual Ride to Conquer Cancer launched on Tuesday to raise vital funds for the cancer programs at Penn Medicine.  Funds raised will be used immediately to support breakthrough cancer research, education and patient care programs at Penn Medicine's Abramson Cancer Center.

"We are absolutely thrilled to announce our first annual Ride to Conquer Cancer benefiting Penn Medicine's Abramson Cancer Center," said Chi Van Dang, MD, PhD, director of the Abramson Cancer Center.

"This year there will be nearly 80,000 cancer diagnoses in Pennsylvania and it's estimated that one in four deaths in the United States will be caused by cancer.  At the Abramson Cancer Center, we are dedicated to reducing cancer incidence, mortality and morbidity in the community while training future cancer researchers and improving our ability to prevent, diagnose and treat cancer.  The funds raised through The Ride will be put to use immediately to power our breakthrough cancer research, and world-class education and patient care programs right here in Philadelphia," said Dr. Dang.

The Ride to Conquer Cancer will be a two-day, 150 mile cycling event through Pennsylvania's picturesque countryside with an overnight camp midway where participants will enjoy pre-set tents, hot meals, showers, live entertainment, massages and other festive activities.  The Ride start and finish will be held on October 11th and 12th of this year, and pit stops with fresh food, beverages and public cheer stations will be set up along the route to support Riders as they pass through local communities.

"I was recently diagnosed with Gastrointestinal Stromal Tumor that is so rare, there is not yet a cure," said Susan Ranck of Springfield, who registered and plans to ride in October.

"I am beyond grateful that funding from research enabled scientists to discover a drug that enables me to at least control my cancer.  Not so long ago, GIST cancer was a practical death sentence, and now there are drug options to offset this terrible disease.  I am here today thanks to research and breakthrough discoveries, so when I learned The Ride is coming to Pennsylvania, I registered immediately. I am excited to ride and it's my hope that with more time and money, the researchers at the Abramson Cancer Center will find a cure for my disease and all forms of cancer," Ranck added.

Dr. Dang said The Ride is a cycling event for everyone and urged people in the Philadelphia region to register, donate or request information by calling (844) 777-7433 or by visiting www.ridetovictory.org

"This event will be remarkable and will bring together communities of cancer survivors, cyclists and their supporters with a common goal to conquer this disease," said Dr. Dang.  We invite everyone to join us in October by registering today at www.ridetovictory.org or by calling (844) 777-7433," Dr. Dang added.

To register, donate or request information about The Ride to Conquer Cancer, visit www.ridetovictory.org or call (844) 777-7433.

ABOUT PENN MEDICINE:
The Abramson Cancer Center of the University of Pennsylvania is a national leader in cancer research, patient care and education, and an integral part of Penn Medicine, one of the world's leading academic health systems. The pre-eminent position of the Cancer Center is reflected in its continuous designation as a Comprehensive Cancer Center by the National Cancer Institute for 40 years. The ACC is home to more than 400 basic, translational and clinical research scientists and physicians who work relentlessly to determine the pathogenesis of cancer, thereby improving the prevention, diagnosis and treatment of this deadly disease. Each year, the ACC's clinical program, comprised of a dedicated staff of physicians, nurse practitioners, nurses, social workers, physical therapists, nutritionists and other professionals, sees more than 90,000 outpatient visits and over 11,800 inpatient stays, and provides more than 110,000 chemotherapy infusions and radiation treatments.

Penn Medicine is dedicated to the related missions of medical education, biomedical research, and excellence in patient care, consisting of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2012, Penn Medicine provided $827 million to benefit our community.

MEDIA CONTACT:
Ailish Steele, Senior Communications Manager
The Ride To Conquer Cancer
Mobile: (855) 287-3953 
Email: [email protected]

SOURCE Ride to Conquer Cancer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"We're focused on how to get some of the attributes that you would expect from an Amazon, Azure, Google, and doing that on-prem. We believe today that you can actually get those types of things done with certain architectures available in the market today," explained Steve Conner, VP of Sales at Cloudistics, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
It is of utmost importance for the future success of WebRTC to ensure that interoperability is operational between web browsers and any WebRTC-compliant client. To be guaranteed as operational and effective, interoperability must be tested extensively by establishing WebRTC data and media connections between different web browsers running on different devices and operating systems. In his session at WebRTC Summit at @ThingsExpo, Dr. Alex Gouaillard, CEO and Founder of CoSMo Software, presented ...
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...
"There's plenty of bandwidth out there but it's never in the right place. So what Cedexis does is uses data to work out the best pathways to get data from the origin to the person who wants to get it," explained Simon Jones, Evangelist and Head of Marketing at Cedexis, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
WebRTC is great technology to build your own communication tools. It will be even more exciting experience it with advanced devices, such as a 360 Camera, 360 microphone, and a depth sensor camera. In his session at @ThingsExpo, Masashi Ganeko, a manager at INFOCOM Corporation, introduced two experimental projects from his team and what they learned from them. "Shotoku Tamago" uses the robot audition software HARK to track speakers in 360 video of a remote party. "Virtual Teleport" uses a multip...
"We work around really protecting the confidentiality of information, and by doing so we've developed implementations of encryption through a patented process that is known as superencipherment," explained Richard Blech, CEO of Secure Channels Inc., in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
High-velocity engineering teams are applying not only continuous delivery processes, but also lessons in experimentation from established leaders like Amazon, Netflix, and Facebook. These companies have made experimentation a foundation for their release processes, allowing them to try out major feature releases and redesigns within smaller groups before making them broadly available. In his session at 21st Cloud Expo, Brian Lucas, Senior Staff Engineer at Optimizely, discussed how by using ne...
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, provided a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to oper...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
In his session at 21st Cloud Expo, James Henry, Co-CEO/CTO of Calgary Scientific Inc., introduced you to the challenges, solutions and benefits of training AI systems to solve visual problems with an emphasis on improving AIs with continuous training in the field. He explored applications in several industries and discussed technologies that allow the deployment of advanced visualization solutions to the cloud.
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
Enterprises are moving to the cloud faster than most of us in security expected. CIOs are going from 0 to 100 in cloud adoption and leaving security teams in the dust. Once cloud is part of an enterprise stack, it’s unclear who has responsibility for the protection of applications, services, and data. When cloud breaches occur, whether active compromise or a publicly accessible database, the blame must fall on both service providers and users. In his session at 21st Cloud Expo, Ben Johnson, C...
SYS-CON Events announced today that Telecom Reseller has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Telecom Reseller reports on Unified Communications, UCaaS, BPaaS for enterprise and SMBs. They report extensively on both customer premises based solutions such as IP-PBX as well as cloud based and hosted platforms.